Craft

Neurotech International

Stock Price

$0

2024-10-04

Market Capitalization

$60 M

2024-10-04

Neurotech International Summary

Company Summary

Overview
Neurotech International is a clinical-stage biopharmaceutical company that provides neurological solutions. It is engaged in research, designs, and produces wearable neurotechnology devices to assist with neurological conditions.
Type
Public
Status
Active
Founded
2016
HQ
Nedlands, AU | view all locations
Website
https://neurotechinternational.com
Cybersecurity rating
Sectors

Key People

  • Mark Davies
  • Gerald Quigley

    Gerald Quigley, Director of Public Relations

    LocationsView all

    1 location detected

    • Nedlands, WA HQ

      Australia

      Suite 5 CPC, 145 Stirling Highway

    Neurotech International Financials

    Summary Financials

    Gross profit (H1, 2026)
    $4.7M
    Net income (H1, 2026)
    ($697.0K)
    Cash (H1, 2026)
    $6.3M
    EBIT (H1, 2026)
    ($697.0K)

    Footer menu